These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3087222)

  • 1. Outpatient treatment of patients with substance abuse and coexisting psychiatric disorders.
    Kofoed L; Kania J; Walsh T; Atkinson RM
    Am J Psychiatry; 1986 Jul; 143(7):867-72. PubMed ID: 3087222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient treatment of the mentally ill chemical abuser: an overview of problems and treatment strategies.
    Amann KR; Harris M
    Soc Work Health Care; 1992; 16(3):29-38. PubMed ID: 1317066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients in a VA ambulatory detoxification program.
    Wiseman EJ; Henderson KL; Briggs MJ
    Psychiatr Serv; 1997 Feb; 48(2):200-3. PubMed ID: 9021850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment for dual diagnosis patients in the psychiatric and substance abuse systems.
    Timko C; Dixon K; Moos RH
    Ment Health Serv Res; 2005 Dec; 7(4):229-42. PubMed ID: 16320106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retention of adolescents with substance dependence and coexisting mental health disorders in outpatient alcohol and drug group therapy.
    Pagey B; Deering D; Sellman D
    Int J Ment Health Nurs; 2010 Dec; 19(6):437-44. PubMed ID: 21054730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term patterns of service use and cost among patients with both psychiatric and substance abuse disorders.
    Hoff RA; Rosenheck RA
    Med Care; 1998 Jun; 36(6):835-43. PubMed ID: 9630125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of outpatient intensive treatment for drug abuse.
    Campbell J; Gabrielli W; Laster LJ; Liskow BI
    J Addict Dis; 1997; 16(2):15-25. PubMed ID: 9083822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment outcome of an outpatient treatment program for dually-diagnosed veterans: the Cincinnati Veterans Affairs Medical Center.
    Sekerka R; Goldsmith RJ; Brandewie L; Somoza E
    J Psychoactive Drugs; 1999; 31(1):85-94. PubMed ID: 10332642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for substance abuse and psychiatric disorders among women patients in a VA Health Care System.
    Davis TM; Bush KR; Kivlahan DR; Dobie DJ; Bradley KA
    Psychiatr Serv; 2003 Feb; 54(2):214-8. PubMed ID: 12556603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social phobia in an outpatient alcohol and drug treatment sample.
    Adamson SJ; Sellman JD; Robertson PJ
    Aust N Z J Psychiatry; 2008 Feb; 42(2):134-40. PubMed ID: 18197508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dropping out of outpatient psychiatric treatment: a preliminary report of a 2-year follow-up of 1500 psychiatric outpatients in Kermanshah, Iran.
    Khazaie H; Rezaie L; de Jong DM
    Gen Hosp Psychiatry; 2013; 35(3):314-9. PubMed ID: 23265950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse in schizophrenia: service utilization and costs.
    Bartels SJ; Teague GB; Drake RE; Clark RE; Bush PW; Noordsy DL
    J Nerv Ment Dis; 1993 Apr; 181(4):227-32. PubMed ID: 8473874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating patients with mental illness and chemical dependency: an intensive outpatient program.
    Goldman CR; Hicks PW; Bennett M; Leggett RP
    J S C Med Assoc; 1994 Mar; 90(3):105-8. PubMed ID: 8189698
    [No Abstract]   [Full Text] [Related]  

  • 14. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term use of VA mental health services by older patients with substance use disorders.
    Brennan PL; Nichols KA; Moos RH
    Psychiatr Serv; 2002 Jul; 53(7):836-41. PubMed ID: 12096166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost and usage impacts of treatment initiation: a comparison of alcoholism and drug abuse treatments.
    Goodman AC; Nishiura E; Humphreys RS
    Alcohol Clin Exp Res; 1997 Aug; 21(5):931-8. PubMed ID: 9267547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the assessment of specialized treatments for substance abuse among people with severe mental illness.
    Jerrell JM; Ridgely MS
    J Psychoactive Drugs; 1995; 27(4):347-55. PubMed ID: 8788691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.
    Choi S; Adams SM; Morse SA; MacMaster S
    Subst Use Misuse; 2015 Apr; 50(5):653-63. PubMed ID: 25587672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current need versus treatment history as predictors of use of outpatient psychiatric care.
    Friedman MJ; West AN
    Am J Psychiatry; 1987 Mar; 144(3):355-7. PubMed ID: 3826437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlinking disability income, substance use and adverse outcomes in dually diagnosed, severely mentally ill outpatients.
    Ries RK; Short RA; Dyck DG; Srebnik DS
    Am J Addict; 2004; 13(4):390-7. PubMed ID: 15370937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.